LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo
Anke Van der Perren, Diego Cabezudo, Géraldine Gelders, Javier María Peralta Ramos, Chris Van den Haute, Veerle Baekelandt, Evy Lobbestael
Topics & Concepts
LRRK2NeuroinflammationNeurodegenerationAlpha-synucleinParkinson's diseaseMedicineNeurologyNeurotoxicityNeuropathologyNeuroscienceDiseaseBiologyPathologyInternal medicineToxicityParkinson's Disease Mechanisms and TreatmentsBotulinum Toxin and Related Neurological DisordersNeurological diseases and metabolism